<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38081885</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Clinical characteristics of Long COVID patients presenting to a dedicated academic post-COVID-19 clinic in Central Texas.</ArticleTitle><Pagination><StartPage>21971</StartPage><MedlinePgn>21971</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">21971</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-48502-w</ELocationID><Abstract><AbstractText>Post-acute sequelae SARS-CoV-2 (PASC), also known as Long COVID, is a complex and widely recognized illness with estimates ranging from 5 to 30% of all COVID-19 cases. We performed a retrospective chart review of patients who presented to a dedicated Post-COVID-19 clinic between June 2021 and May 2022. The median patient age was 44.5 years, 63.5% patients were female, and patients presented at a median of 10.4 months from acute COVD-19 infection. 78% self-identified their race as white, and 21% identified as Latino ethnicity. During the acute COVID-19 infection, 50% of patients experienced moderate disease severity and 10.5% were hospitalized. The top three co-morbid conditions prior to SARS-CoV-2 infection included mental health conditions, hypertension and asthma. Patients reported a median of 18 new symptoms following COVID-19 illness, the most common were fatigue (89%), forgetfulness or "brain fog" (89%), and difficulty concentrating (77%). MoCA (Montreal Cognitive Assessment) assessment demonstrated that 46% had mild cognitive dysfunction. PHQ-9 (Patient Health Questionnaire) testing revealed 42% had moderate to severe depression, and 38% had moderate to severe anxiety on the GAD-7 (Generalized Anxiety Disorder) assessment. Symptom burden was similar across gender, age, and initial disease severity. PASC patients presenting to an academic Post-COVID-19 clinic experienced numerous multisystem symptoms and functional impairment, independent of the initial COVID-19 disease severity.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Rija</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siles</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelley</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wylie</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melamed</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Dell Medical School, University of Texas at Austin, Austin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brode</LastName><ForeName>W Michael</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School, University of Texas at Austin, Austin, USA. william.brode@austin.utexas.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013781" MajorTopicYN="N" Type="Geographic">Texas</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>17</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38081885</ArticleId><ArticleId IdType="pmc">PMC10713530</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-48502-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-48502-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Long COVID or post-COVID conditions. CDC https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (2022).</Citation></Reference><Reference><Citation>Lara Bull-Otterson, PhD. et al. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 Years &#x2014; United States. CDC https://www.cdc.gov/mmwr/volumes/71/wr/mm7121e1.htm (2022).</Citation></Reference><Reference><Citation>Logue JK, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4:e210830. doi: 10.1001/jamanetworkopen.2021.0830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw. Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus. WHO https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264. doi: 10.1016/S0140-6736(22)00941-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: Community-based, matched cohort study. Open Forum Infect. Dis. 2022;9:ofac464. doi: 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach, K. Is &#x2018;long Covid&#x2019; worsening the labor shortage? Brookings https://www.brookings.edu/research/is-long-covid-worsening-the-labor-shortage (2022).</Citation></Reference><Reference><Citation>Post-COVID Care Centers. SurvivorCorps post-COVID care centers&#x2014;survivor corps (2023).</Citation></Reference><Reference><Citation>Ladyzhets, B. Where are the long COVID clinics? ScienceNews https://www.sciencenews.org/article/long-covid-clinics-map-locations-prevalence. (2022).</Citation></Reference><Reference><Citation>Vanichkachorn G, et al. Post-COVID-19 syndrome (long haul syndrome): Description of a multidisciplinary clinic at mayo clinic and characteristics of the initial patient cohort. Mayo Clin. Proc. 2021;96:1782&#x2013;1791. doi: 10.1016/j.mayocp.2021.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.024</ArticleId><ArticleId IdType="pmc">PMC8112396</ArticleId><ArticleId IdType="pubmed">34218857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali ST, et al. Evolution of neurologic symptoms in non-hospitalized COVID-19 "long haulers". Ann. Clin. Transl. Neurol. 2022;9:950&#x2013;961. doi: 10.1002/acn3.51570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51570</ArticleId><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau O, et al. Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution. JAMA Netw. Open. 2022;5:e2240985. doi: 10.1001/jamanetworkopen.2022.40985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40985</ArticleId><ArticleId IdType="pmc">PMC9647489</ArticleId><ArticleId IdType="pubmed">36350653</ArticleId></ArticleIdList></Reference><Reference><Citation>Underlying medical conditions associated with higher risk for severe COVID-19: Information for Healthcare Professionals. CDC Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals|CDC (2023).</Citation></Reference><Reference><Citation>Shanley JE, et al. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms. Ann. Clin. Transl. Neurol. 2022;9:995&#x2013;1010. doi: 10.1002/acn3.51578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51578</ArticleId><ArticleId IdType="pmc">PMC9268882</ArticleId><ArticleId IdType="pubmed">35702954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, et al. Long COVID through a public health lens: An umbrella review. Public Health Rev. 2022;43:1604501. doi: 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A, et al. COVID-19 vaccine and long COVID: A scoping review. Life (Basel) 2022 doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, et al. Myalgic encephalomyelitis: International consensus criteria. J. Intern. Med. 2011;270:327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V, et al. Premorbid vulnerability and disease severity impact on long-COVID cognitive impairment. Aging Clin. Exp. Res. 2022;34:257&#x2013;260. doi: 10.1007/s40520-021-02042-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-02042-3</ArticleId><ArticleId IdType="pmc">PMC8747881</ArticleId><ArticleId IdType="pubmed">35014002</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. 2022;18:1047&#x2013;1066. doi: 10.1002/alz.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12644</ArticleId><ArticleId IdType="pmc">PMC9073922</ArticleId><ArticleId IdType="pubmed">35297561</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long covid-19. N. Engl. J. Med. 2022;387:1813&#x2013;1815. doi: 10.1056/NEJMcibr2210069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristillo V, et al. Predictors of "brain fog" 1 year after COVID-19 disease. Neurol. Sci. 2022;43:5795&#x2013;5797. doi: 10.1007/s10072-022-06285-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06285-4</ArticleId><ArticleId IdType="pmc">PMC9361921</ArticleId><ArticleId IdType="pubmed">35930181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazumi M, Usuda K, Okazaki E, Kataoka M, Nishi D. Differences in the course of depression and anxiety after COVID-19 infection between recovered patients with and without a psychiatric history: A cross-sectional study. Int. J. Environ. Res. Public Health. 2022 doi: 10.3390/ijerph191811316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191811316</ArticleId><ArticleId IdType="pmc">PMC9517442</ArticleId><ArticleId IdType="pubmed">36141588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, et al. Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 2022 doi: 10.1186/s12967-022-03328-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur. Respir. J. 2023 doi: 10.1183/13993003.00970-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur JM, et al. Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021;16:e0257016. doi: 10.1371/journal.pone.0257016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257016</ArticleId><ArticleId IdType="pmc">PMC8415618</ArticleId><ArticleId IdType="pubmed">34478478</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K, Chan D, Watermeyer T. The cognitive consequences of the COVID-19 epidemic: Collateral damage? Brain Commun. 2020;2:fcaa069. doi: 10.1093/braincomms/fcaa069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa069</ArticleId><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ML, et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT. PLoS One. 2021;16:e0254347. doi: 10.1371/journal.pone.0254347.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: Cohort description and approaches for measurement. Open Forum Infect. Dis. 2022;9:ofab640. doi: 10.1093/ofid/ofab640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab640</ArticleId><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska JB, Kuczynska K. Psychiatric and neurological complications of long COVID. J. Psychiatr. Res. 2022;156:349&#x2013;360. doi: 10.1016/j.jpsychires.2022.10.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.10.045</ArticleId><ArticleId IdType="pmc">PMC9582925</ArticleId><ArticleId IdType="pubmed">36326545</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman ML, Molldrem S, Elliott A, Robertson D, Keiser P. Long COVID and mental health correlates: A new chronic condition fits existing patterns. Health Psychol. Behav. Med. 2023;11:2164498. doi: 10.1080/21642850.2022.2164498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21642850.2022.2164498</ArticleId><ArticleId IdType="pmc">PMC9833408</ArticleId><ArticleId IdType="pubmed">36643576</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical spectrum of SARS-CoV-2 Infection. NIH https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. (2023).</Citation></Reference><Reference><Citation>Global COVID-19 clinical platform case report form (CRF) for Post COVID condition (Post COVID-19 CRF), WHO Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF) (who.int) (2021).</Citation></Reference><Reference><Citation>Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual. Life Res. 2009;18:873&#x2013;880. doi: 10.1007/s11136-009-9496-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-009-9496-9</ArticleId><ArticleId IdType="pmc">PMC2724630</ArticleId><ArticleId IdType="pubmed">19543809</ArticleId></ArticleIdList></Reference><Reference><Citation>PROMIS&#xae; score cut points, HealthMeasures https://www.healthmeasures.net/score-and-interpret/interpret-scores/promis/promis-score-cut-points (2021).</Citation></Reference><Reference><Citation>Levis B, Benedetti A, Thombs BD, Collaboration DESD. Accuracy of Patient Health questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis. BMJ. 2019;365:l1476. doi: 10.1136/bmj.l1476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1476</ArticleId><ArticleId IdType="pmc">PMC6454318</ArticleId><ArticleId IdType="pubmed">30967483</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinz A, et al. Psychometric evaluation of the generalized anxiety disorder screener GAD-7, based on a large German general population sample. J. Affect. Disord. 2017;210:338&#x2013;344. doi: 10.1016/j.jad.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2016.12.012</ArticleId><ArticleId IdType="pubmed">28088111</ArticleId></ArticleIdList></Reference><Reference><Citation>Kar N, Kar B, Kar S. Stress and coping during COVID-19 pandemic: Result of an online survey. Psychiatry Res. 2021;295:113598. doi: 10.1016/j.psychres.2020.113598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113598</ArticleId><ArticleId IdType="pmc">PMC7688436</ArticleId><ArticleId IdType="pubmed">33264677</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>